Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-398P is a processed pseudogene sequence derived from the U6 small nuclear RNA gene (snRNA). U6 snRNA is an essential component of the spliceosome, participating in the removal of introns from pre-mRNA in eukaryotes. Pseudogenes like RNU6-398P arise by retrotransposition events in which a copy of U6 snRNA is reverse-transcribed and inserted into the genome. As a pseudogene, RNU6-398P does not encode a functional RNA and generally lacks regulatory regions required for transcription[2][3][4]. Most processed pseudogenes, including those from snRNAs, are considered nonfunctional, having no known role in cellular biology, disease, or pharmaceutical targeting[2][4]. The existence of these pseudogenes is a common feature of vertebrate genomes and underscores the evolutionary importance of the parent U6 snRNA gene, but the pseudogene itself is not an active element in gene expression, splicing, or disease mechanisms[3][4]. Key notes: - RNU6-398P is not a functional receptor, enzyme, transporter, or drug target. - It is a processed pseudogene (more specifically, a pseudogene of a small nuclear RNA gene), thus it is not a therapeutic target[4][2]. - "RNU6-398P" is the standard gene name/abbreviation for this sequence. - No drugs, biomarkers, or disease roles are associated with this pseudogene. - If your intent is to find functional or druggable targets, this is not an appropriate entry, and its inclusion as a "target" would be considered incorrect in most biomedical contexts[2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 398, pseudogene (RNU6-398P).